Nalaganje...

3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis

BACKGROUND: Concurrent chemoradiotherapy with cisplatin is standard for patients (pts) with loco-regionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) and for patients with resected SCCHN with high-risk features. The standard regimen includes 3-weekly cisplatin, but weekly regi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Radiat Oncol
Main Authors: Helfenstein, Seth, Riesterer, Oliver, Meier, Urs R., Papachristofilou, Alexandros, Kasenda, Benjamin, Pless, Miklos, Rothschild, Sacha I.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6371614/
https://ncbi.nlm.nih.gov/pubmed/30744643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-019-1235-y
Oznake: Označite
Brez oznak, prvi označite!